Pharmaceutical industry sales expense ratio hits 8-year high

A pharmaceutical company's annual cost of sales can reach tens of billions! Almost no industry has higher sales expenses than the pharmaceutical industry. Therefore, the sales expenses of pharmaceutical companies have become a topic of interest to the media, and relevant reports came out just after the disclosure of this year's interim results.Wind data statistics show that the sales expenses disclosed by pharmaceutical companies in the middle of this year are still growing year-on-year, and the total sales expenses of 304 companies reached 136.153 billion yuan, an increase of 17.64% year-on-year and a slight decrease from the previous year.

In the context of the national crackdown on drug rebates and the Ministry of Finance's inspection of 77 pharmaceutical companies' accounting information, sales expenses increased rather than decreased year-on-year, seemingly becoming a "persistent problem". In fact, the high growth of sales expense in the pharmaceutical industry is not a real scenario. This is to start from the industry operating rules and policy background.